A cohort study on the comparison of Zhongshan methods and NIH risk assessment system for the study of benign and malignant gastrointestinal stromal tumors (GISTs), staging and grading

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036165

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal stromal tumor (GIST)

Interventions

Subjects were grouped according to NIH risk assessment method and Zhongshan assessment method:Nil

Eligibility

Sex/Gender

All

Age

10 Years to 90 Years

Inclusion criteria

Inclusion criteria: Pathological resuls of turgical specimen was GIST in patients dignosed by our center.

Exclusion criteria

Exclusion criteria: 1.The clinicopathological information was incomplete, lacking of the following details:type of surgical excision specimens, tumor location, general descriptions description (tumor size), mitotic phase, immunohistochemical results and so on. 2.Patients with the secondary gist (including recurrent and metastatic GIST). 3.Patients who accepted preoperative targeted therapy(neoadjuvant therapy). 4.Patients lost to follow-up within 1 year.

Design outcomes

Primary

Measure	Time frame
disease-free survival;	—

Countries

China

Contacts

Public ContactYingyong Hou

Zhongshan Hospital Fudan University(Department of Pathology)

houyingyong@hotmail.com+86 13681972385

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026